查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
床旁分子診斷市場 - 增長、未來展望、競爭分析，2023 年至 2031 年
市場調查報告書
商品編碼
1255967

床旁分子診斷市場 - 增長、未來展望、競爭分析，2023 年至 2031 年

Point of Care Molecular Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

在 2023 年至 2031 年的預測期內，全球即時分子診斷市場預計將以 8.5% 的複合年增長率增長。 床旁分子診斷市場的興起主要是由於傳染病和癌症的流行率不斷上升，以及終端用戶因其吸引人的特性而對床旁分子檢測的需求不斷增加。 長期以來，醫療專業人員一直在實驗室和其他醫療機構中使用分子診斷技術。 然而，高昂的測試成本、耗時的測試以及分子診斷的延遲發現促使人們尋找替代診斷方法。 在此背景下，床旁型分子診斷藥物市場備受矚目。 由於床旁分子診斷能夠縮短周轉時間並提供快速、可靠的結果，因此在包括醫院和研究實驗室在內的垂直最終用途中獲得了巨大的吸引力。 床旁分子檢測可以在實驗室外對疾病進行快速和早期診斷。 通常，這些測試是在患者附近進行的。

推動床旁分子診斷市場增長的一個關鍵因素是越來越多地使用床旁分子診斷解決方案來早期檢測各種疾病，從呼吸系統疾病和癌症到性傳播疾病疾病和胃腸道疾病。招聘人數正在增加。 展望未來，在新興國家健康意識提高的推動下，分子診斷和分子成像市場的快速擴張有望為床旁分子診斷製造商創造機會。 除了微流控技術和基因序列分析的最新進展外，低成本、快速的 POC 分子診斷平台的開發有望促進 POC 分子診斷設備的銷售並擴大分子 POC 檢測市場。

感染和惡性腫瘤的頻率增加

發達國家和新興國家傳染病和癌症發病率的上升將對床旁分子診斷市場的增長產生積極影響。 分子診斷的處方頻率增加是由於這些疾病的診斷和治療。 預計在預測期內，上述原因和預防醫學的上升趨勢將推動對即時分子診斷的需求。

新興國家的業務擴張機會

印度、韓國、巴西和墨西哥等新興經濟體為床旁分子診斷領域的市場進入者提供了巨大的增長潛力。 這是由於監管障礙低、醫療基礎設施的進步、患者數量增加、傳染病流行以及醫療成本上升。 此外，這些國家的監管政策比發達國家的監管政策更具適應性和商業友好性。

不利的還款情況限制了市場增長

醫療報銷不足是抑制臨床分子診斷市場增長的主要因素。 讓醫療保險和私人醫療支付者為診斷測試付費是大多數診斷測試商業化的主要障礙。 2018 年，美國醫療保險更新了多項 IVD 檢測的資助流程，包括床旁分子診斷。 其中一些測試使用未註冊的醫療保健通用程序編碼系統 (HCPCS) 代碼計費。 在這些情況下，Medicare Managed Contractor (MAC) 設定應付給每個市政當局的金額。 CMS 已將其基於高通量技術的 COVID-19 測試的醫療保險支付率降至 75 美元，除非實驗室可以在兩天內處理結果。 Medicare 目前不資助沒有癌症家族史的人進行基因檢測（來源：美國臨床腫瘤學會）。

按應用，傳染病引領市場

分子診斷中的 PoC 測試有許多應用，包括傳染病控制、腫瘤學、血液學、產前篩查和內分泌學中的臨近患者測試。 在傳染病和腫瘤學領域，床旁 (PoC) 分子檢測取得了最大的基於應用的進步。 到 2022 年，傳染病領域的收入份額將最大。 傳染病的快速分子診斷測試有助於通過提供和促進適當的抗生素治療、加快疾病控制、加強醫療實驗室資產的分配、降低死亡率和醫療支出來增加收入份額。

就技術而言，基於 PCR 的檢測引領市場

按技術劃分，床旁分子診斷市場分為基於 PCR、基於基因序列、基於雜交和基於微陣列的測試和設備。 到 2022 年，基於 PCR 的測試將佔據最大的收入份額。 市場將受到床旁診斷商業化的推動，這些診斷能夠對 H1N1 和流感等傳染病進行準確、快速的實時 PCR 分析。 由於該行業的眾多進步，預計在預測期內，貼近患者的基於 NGS 的分子檢測將出現顯著增長。 創新的平台改進能夠在即時護理和快速診斷中實現高度準確的基因測序和 DNA 數據處理，這有助於該細分市場的預期增長。 由於市場領導者的持續創新和研發努力，快速 DNA 分析有望在未來幾年內實現顯著增長。

在預測期內，OTC 測試將按測試地點主導市場

市場分為概念驗證 (PoC) 和場外交易 (OTC) 測試，具體取決於測試地點。 OTC 測試的多功能性和便攜性優於家庭和療養院使用的 POC 測試。 大多數 OTC 用戶是未經培訓的專業人員，在大多數情況下，是患者本人。 此外，其中許多測試都是 CLIA 豁免的，鼓勵非實驗室使用。 由於其易用性、可訪問性和高采用率，預計場外交易 (OTC) 測試將在預測期內產生可觀的收入。

在最終用戶方面，分佈式實驗室引領市場

按最終用途，市場分為分佈式實驗室、醫院、家庭護理、輔助醫療設施等。 到 2022 年，分佈式實驗室將獲得最大的收入份額。 與基於中央實驗室的同行相比，這些測試的物理足跡要小得多，而且它們提供快速準確的分子分析的能力是該領域收入份額增長的關鍵驅動力。

亞太地區仍然是增長最快的地區

市場進入者的不懈努力對增加市場份額做出了重大貢獻。 此外，許多臨床研究驗證了新型分子測試的有效性和準確性，預計將有助於在預測期內擴大市場。 對快速診斷的日益增長的需求以及用於 DNA 分析的創新分子診斷方法的引入使歐洲成為一個重要的利基市場。 由於缺乏先進的中央實驗室檢測服務、需要臨床檢測的大量人口以及引入具有成本效益的 PoC 分子檢測的潛力，亞太地區將在預測期內實現最高增長。預計將創下記錄。

內容

第一章前言

  • 報告內容
    • 報告的目的
    • 目標受眾
    • 主要產品
  • 市場細分
  • 調查方法
    • 第一階段 - 二次調查
    • 第二階段 - 初步研究
    • 第三階段 - 專家評審
    • 先決條件
    • 採用的方法

第 2 章執行摘要

  • 市場概況：全球床旁分子診斷市場
  • 全球床旁分子診斷市場：按產品和服務分類，2022 年
  • 全球床旁分子診斷市場：按技術分類，2022 年
  • 全球床旁分子診斷市場：按應用分類，2022 年
  • 全球床旁分子診斷市場：按最終用戶分類，2022 年
  • 全球床旁分子診斷市場：按地區劃分，2022 年
  • 有吸引力的投資建議：按地區劃分，2022 年

第 3 章床旁分子診斷市場：競爭分析

  • 主要供應商的市場定位
  • 供應商採用的策略
  • 主要產業戰略
  • 等級分析：2022 年與 2031 年

第 4 章護理點分子診斷市場：宏觀分析和市場動態

  • 簡介
  • 2021-2031 年全球床旁分子診斷市場價值
  • 市場動態
    • 市場驅動力
    • 市場製約因素
    • 主要問題
    • 主要機會
  • 促進因素和抑制因素的影響分析
  • 蹺蹺板分析

第 5 章護理點分子診斷市場：按產品和服務分類，2021 年至 2031 年

  • 市場概覽
  • 增長和收益分析：2022 年與 2031 年
  • 市場細分
    • 化驗和試劑盒
    • 儀器和分析儀
    • 軟件和服務

第 6 章護理點分子診斷市場：按技術分類，2021-2031

  • 市場概覽
  • 增長和收益分析：2022 年與 2031 年
  • 市場細分
    • RT-PCR
    • 惰性
    • 其他技術

第 7 章護理點分子診斷市場：按應用分類，2021 年至 2031 年

  • 市場概覽
  • 增長和收益分析：2022 年與 2031 年
  • 市場細分
    • 呼吸系統疾病
    • 性傳播疾病
    • 院內感染
    • 癌症
    • 肝炎
    • 胃腸道疾病
    • 其他應用

第 8 章護理點分子診斷市場：按最終用戶分類，2021 年至 2031 年

  • 市場概覽
  • 增長和收益分析：2022 年與 2031 年
  • 市場細分
    • 醫務室
    • 醫院和 ICU
    • 調查
    • 其他最終用戶

第 9 章北美護理點分子診斷市場 2021-2031

  • 市場概覽
  • 床旁分子診斷市場：2021-2031 年（按產品和服務）
  • 床旁分子診斷市場：2021-2031 年（按技術）
  • 床旁分子診斷市場：按應用分類，2021 年至 2031 年
  • 床旁分子診斷市場：按最終用戶劃分，2021-2031 年
  • 床旁分子診斷市場：2021-2031 年（按地區劃分）
    • 北美
      • 美國
      • 加拿大
      • 其他北美地區

第 10 章英國和歐盟護理點分子診斷市場 2021-2031

  • 市場概覽
  • 床旁分子診斷市場：按產品/服務分類，2021 年-2031年
  • 床旁分子診斷市場：2021-2031 年（按技術）
  • 床旁分子診斷市場：按應用分類，2021 年至 2031 年
  • 床旁分子診斷市場：按最終用戶劃分，2021-2031 年
  • 床旁分子診斷市場：2021-2031 年（按地區劃分）
    • 英國和歐盟
      • 英國
      • 德國
      • 西班牙
      • 意大利
      • 法國
      • 其他歐洲地區

第 11 章亞太護理點分子診斷市場 2021-2031

  • 市場概覽
  • 床旁分子診斷市場：2021-2031 年（按產品和服務）
  • 床旁分子診斷市場：2021-2031 年（按技術）
  • 床旁分子診斷市場：按應用分類，2021 年至 2031 年
  • 床旁分子診斷市場：按最終用戶劃分，2021-2031 年
  • 床旁分子診斷市場：2021-2031 年（按地區劃分）
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區

第 12 章拉丁美洲護理點分子診斷市場 2021-2031

  • 市場概覽
  • 床旁分子診斷市場：2021-2031 年（按產品和服務）
  • 床旁分子診斷市場：2021-2031 年（按技術）
  • 床旁分子診斷市場：按應用分類，2021 年至 2031 年
  • 床旁分子診斷市場：按最終用戶劃分，2021-2031 年
  • 床旁分子診斷市場：2021-2031 年（按地區劃分）
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地區

第 13 章中東和非洲護理點分子診斷市場 2021-2031

  • 市場概覽
  • 床旁分子診斷市場：2021-2031 年（按產品和服務）
  • 床旁分子診斷市場：2021-2031 年（按技術）
  • 床旁分子診斷市場：按應用分類，2021 年至 2031 年
  • 床旁分子診斷市場：按最終用戶劃分，2021-2031 年
  • 床旁分子診斷市場：2021-2031 年（按地區劃分）
    • 中東和非洲
      • 海灣合作委員會
      • 非洲
      • 其他中東和非洲地區

第14章公司簡介

  • Abbott Laboratories（U.S.）
  • F. Hoffmann-La Roche Ltd.（Switzerland）
  • bioMerieux S.A.（France）
  • Danaher Corporation（U.S.）
  • Quidel Corporation（U.S.）
  • QIAGEN N.V.（Netherlands）
  • Co-Diagnostics Inc.
  • Biocartis NV（Belgium）
  • Meridian Bioscience Inc.（U.S.）
  • Thermo Fisher Scientific Inc.（U.S.）
Product Code: 139508-04-23

The global market for point-of-care molecular diagnostics is anticipated to expand at a CAGR of 8.5% during the forecast period of 2023 and 2031. The rise of the point-of-care molecular diagnostics market is primarily driven by the increasing prevalence of infectious diseases and cancer, as well as the growing desire of end users for point-of-care molecular testing due to its attractive features. Medical personnel has long utilized molecular diagnostics in laboratories and other healthcare settings. However, the expensive cost of testing, the time-consuming nature, and the delayed findings of molecular diagnostics has encouraged them to seek out alternative diagnostic methods. This has brought the market for molecular diagnostics at the point-of-care into the limelight. Point-of-care molecular diagnostics has acquired significant traction across end-use verticals, including hospitals and research institutes, due to its ability to cut turnaround time and deliver reliable results quickly. Molecular testing at the point of care enables the rapid and early diagnosis of illnesses in non-laboratory settings. Typically, these tests are administered at the locations of close patients.

A key factor driving the growth of the point-of-care molecular diagnostics market is the increasing adoption of point-of-care molecular diagnostic solutions for the early detection of a wide range of diseases, from respiratory diseases and cancer to sexually transmitted diseases and gastrointestinal disorders. In the future years, the rapid expansion of the molecular diagnostics and molecular imaging markets, fueled by rising health consciousness in emerging nations, will generate possibilities for point-of-care molecular diagnostics producers. In addition, recent advances in microfluidics and genetic sequencing, along with the development of low-cost and speedy point-of-care molecular diagnostic platforms, will increase sales of POC molecular diagnostics devices, thereby growing the market for molecular POC tests.

Rising Frequency of Infectious and Malignant Diseases

The rising incidence of infectious diseases and cancer in both developed and emerging regions will favorably impact the growth of the market for point-of-care molecular diagnostics. The increasing frequency of prescriptions for molecular diagnostic tests is attributable to the diagnosis and treatment of such disorders. Demand for point-of-care molecular diagnostics is anticipated to be driven over the projected period by the aforementioned causes and the growing trend toward preventive medicine.

Opportunities For Expansion in Emerging Nations

Emerging economies such as India, South Korea, Brazil, and Mexico present substantial growth potential to market participants in the point-of-care molecular diagnostics sector. This is due to low regulatory hurdles, advancements in healthcare infrastructure, a growing patient population, an increase in the prevalence of infectious diseases, and rising healthcare expenditures. In addition, the regulatory policies of several of these nations are more adaptable and business-friendly than those of developed nations.

Unfavorable Reimbursement Scenario to Limit the Market Growth

Inadequate reimbursements are a major factor inhibiting the growth of the market for molecular diagnostics at the point of care. Getting Medicare and private health insurers to pay for diagnostic testing is a significant obstacle to the commercialization of most diagnostic tests. In 2018, Medicare in the United States updated its funding process for several IVD tests, including point-of-care molecular diagnostics. Several of these tests are billed using unlisted Healthcare Common Procedure Coding System (HCPCS) codes. In such instances, Medicare Administrative Contractors (MACs) establish a payment amount for their respective local governments. CMS cut the Medicare payment rate for COVID-19 tests based on high throughput technology to USD 75 unless laboratories can process findings in less than two days. Medicare does not currently fund genetic testing for those without a cancer family history (Source: American Society of Clinical Oncology).

Infectious Diseases Led the Market by Application

PoC testing in molecular diagnostics has many uses, including testing near the patient in infectious disease management, oncology, hematology, prenatal screening, and endocrinology. In the disciplines of infectious illnesses and oncology, point-of-care (PoC) molecular testing has seen the greatest application-based advancements. In 2022, the infectious diseases segment had the biggest revenue share. Contributing to the revenue share of infectious diseases for rapid molecular diagnostic tests are the provision and facilitation of appropriate antibiotic therapy, faster disease management, enhanced distribution of healthcare laboratory assets, and reductions in mortality and healthcare expenditures.

PCR Based Testing Led the Market by Technology

On the basis of technology, the market for point-of-care molecular diagnostics has been divided into PCR-based, genetic sequencing-based, hybridization-based, and microarray-based tests and devices. In 2022, PCR-based testing generated the greatest revenue share. The market will be driven by the commercialization of point-of-care diagnostics that deliver accurate, rapid real-time PCR analysis for infectious illnesses such as H1N1 and influenza. Due to a number of industry advances, NGS-based molecular testing in close proximity to the patient is expected to have substantial growth during the projection period. Innovative platform modifications that enable genetic sequencing and DNA data processing at the point of care with high precision and give speedy diagnosis contribute to the predicted growth of this market sector. Rapid DNA analysis is anticipated to have substantial growth in the next years as a result of the continuing innovation and R&D efforts of market leaders.

OTC Tests to Dominate During the Forecast Period for Market by Test Site

The market is divided into Proof-of-Concept (PoC) and Over-the-Counter (OTC) tests, depending on the location of the tests. The versatility and portability of OTC tests are superior to POC tests for use in homes and assisted care facilities. The majority of OTC users are untrained professionals and, in the majority of cases, the patients themselves. In addition, a number of these testing instruments are exempt from CLIA, which encourages their use outside of laboratories. Over-the-counter (OTC) tests are anticipated to create more revenue during the projected period due to their usability, accessibility, and higher adoption rate.

Decentralized Laboratories Led the Market by End User

The market is segmented by end-use into decentralized laboratories, hospitals, home care, and assisted living healthcare facilities, among others. In 2022, decentralized laboratories generated the greatest revenue share. The ability of these tests to provide speedy and accurate molecular analysis with a substantially smaller physical footprint than their central laboratory-based equivalents is a crucial driver in the segment's greater revenue share.

APAC to Remain the Fastest Growing Region

Continuous efforts by big market participants to bolster their market position are a significant contributor to the majority share. In addition, a number of clinical studies examining the efficacy and precision of novel molecular tests are anticipated to contribute to the expansion of the market throughout the forecast period. The growing need for speedy diagnosis and the introduction of innovative molecular diagnostic procedures for DNA analysis has positioned Europe as a significant market niche. Due to a lack of advanced central laboratory testing services, a bigger population base requiring clinical testing, and the potential cost-effective implementation of PoC molecular assays, Asia Pacific is predicted to experience the highest growth rate over the forecast period.

Innovations Remain as the Key to Enhance Market Shares

Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), bioMerieux S.A. (France), Danaher Corporation (U.S.), Quidel Corporation (U.S.), QIAGEN N.V. (Netherlands), Co-Diagnostics, Inc. Biocartis NV (Belgium), Meridian Bioscience, Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.). These firms are continually concentrating on the development of innovative point-of-care molecular diagnostic platforms, such as the point-of-care molecular COVID test and paper-based nucleic acid amplification assays, which may diagnose diseases with relative simplicity. In addition, they have utilized techniques such as mergers, acquisitions, and alliances, among others, to increase its global presence.

  • In March 2020, Abbott Laboratories will release the ID NOW point-of-care test for coronavirus detection.
  • In July 2021, QuantuMDx introduced Q-POCTM, a fast PCR diagnostic technology for the point of care.
  • Co-Diagnostics, a molecular diagnostics company, successfully acquired Idaho Molecular and Advanced Conceptions in 2022.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Point of Care Molecular Diagnostics market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Point of Care Molecular Diagnostics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product & Service

  • Assays & kits
  • Instruments &Analyzers
  • Software & Services

Technology

  • RT-PCR
  • INAAT
  • Other technologies

Application

  • Respiratory Diseases
  • Sexually Transmitted Diseases
  • Hospital-acquired Infections
  • Cancer
  • Hepatitis
  • Gastrointestinal Disorders
  • Other Applications

End User

  • Physicians' Offices
  • Hospitals & ICUs
  • Research Institutes
  • Other End Users

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Point of Care Molecular Diagnostics market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Point of Care Molecular Diagnostics market?
  • Which is the largest regional market for Point of Care Molecular Diagnostics market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Point of Care Molecular Diagnostics market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Point of Care Molecular Diagnostics market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Point of Care Molecular Diagnostics Market
  • 2.2. Global Point of Care Molecular Diagnostics Market, By Product & Service, 2022 (US$ Million)
  • 2.3. Global Point of Care Molecular Diagnostics Market, By Technology, 2022 (US$ Million)
  • 2.4. Global Point of Care Molecular Diagnostics Market, By Application, 2022 (US$ Million)
  • 2.5. Global Point of Care Molecular Diagnostics Market, By End User, 2022 (US$ Million)
  • 2.6. Global Point of Care Molecular Diagnostics Market, By Geography, 2022 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2022

3. Point of Care Molecular Diagnostics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Point of Care Molecular Diagnostics Market Vendors
  • 3.2. Strategies Adopted by Point of Care Molecular Diagnostics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Point of Care Molecular Diagnostics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Point of Care Molecular Diagnostics Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Assays & kits
    • 5.3.2. Instruments &Analyzers
    • 5.3.3. Software & Services

6. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. RT-PCR
    • 6.3.2. INAAT
    • 6.3.3. Other technologies

7. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Respiratory Diseases
    • 7.3.2. Sexually Transmitted Diseases
    • 7.3.3. Hospital-acquired Infections
    • 7.3.4. Cancer
    • 7.3.5. Hepatitis
    • 7.3.6. Gastrointestinal Disorders
    • 7.3.7. Other Applications

8. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 8.3. Market Segmentation
    • 8.3.1. Physicians' Offices
    • 8.3.2. Hospitals & ICUs
    • 8.3.3. Research Institutes
    • 8.3.4. Other End Users

9. North America Point of Care Molecular Diagnostics Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
  • 9.3. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 9.4. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 9.5. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
  • 9.6.Point of Care Molecular Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 9.6.1.1.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 9.6.1.1.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.1.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 9.6.1.2.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 9.6.1.2.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.2.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 9.6.1.3.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 9.6.1.3.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.3.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)

10. UK and European Union Point of Care Molecular Diagnostics Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
  • 10.3. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 10.4. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 10.5. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
  • 10.6.Point of Care Molecular Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 10.6.1.1.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 10.6.1.1.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.1.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 10.6.1.2.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 10.6.1.2.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.2.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 10.6.1.3.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 10.6.1.3.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.3.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 10.6.1.4.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 10.6.1.4.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.4.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 10.6.1.5.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 10.6.1.5.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.5.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 10.6.1.6.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 10.6.1.6.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.6.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)

11. Asia Pacific Point of Care Molecular Diagnostics Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
  • 11.3. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 11.4. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 11.5. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
  • 11.6.Point of Care Molecular Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 11.6.1.1.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 11.6.1.1.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.1.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 11.6.1.2.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 11.6.1.2.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.2.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 11.6.1.3.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 11.6.1.3.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.3.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 11.6.1.4.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 11.6.1.4.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.4.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 11.6.1.5.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 11.6.1.5.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.5.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 11.6.1.6.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 11.6.1.6.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.6.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)

12. Latin America Point of Care Molecular Diagnostics Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
  • 12.3. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 12.4. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 12.5. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
  • 12.6.Point of Care Molecular Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 12.6.1.1.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 12.6.1.1.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.1.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 12.6.1.2.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 12.6.1.2.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.2.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 12.6.1.3.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 12.6.1.3.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.3.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)

13. Middle East and Africa Point of Care Molecular Diagnostics Market, 2021-2031, USD (Million)

  • 13.1. Market Overview
  • 13.2. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
  • 13.3. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 13.4. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 13.5. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
  • 13.6.Point of Care Molecular Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 13.6.1.1.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 13.6.1.1.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.1.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 13.6.1.2.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 13.6.1.2.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.2.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 13.6.1.3.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 13.6.1.3.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.3.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)

14. Company Profile

  • 14.1. Abbott Laboratories (U.S.)
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. F. Hoffmann-La Roche Ltd. (Switzerland)
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. bioMerieux S.A. (France)
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Danaher Corporation (U.S.)
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. Quidel Corporation (U.S.)
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. QIAGEN N.V. (Netherlands)
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. Co-Diagnostics, Inc.
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. Biocartis NV (Belgium)
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives
  • 14.9. Meridian Bioscience, Inc. (U.S.)
    • 14.9.1. Company Overview
    • 14.9.2. Financial Performance
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Initiatives
  • 14.10. Thermo Fisher Scientific, Inc. (U.S.)
    • 14.10.1. Company Overview
    • 14.10.2. Financial Performance
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Initiatives
  • 14.11. Others
    • 14.11.1. Company Overview
    • 14.11.2. Financial Performance
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 2 Global Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 3 Global Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 4 Global Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 5 North America Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 6 North America Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 7 North America Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 8 North America Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 9 U.S. Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 10 U.S. Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 11 U.S. Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 12 U.S. Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 13 Canada Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 14 Canada Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 15 Canada Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 16 Canada Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 17 Rest of North America Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 18 Rest of North America Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 19 Rest of North America Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 20 Rest of North America Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 21 UK and European Union Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 22 UK and European Union Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 23 UK and European Union Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 24 UK and European Union Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 25 UK Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 26 UK Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 27 UK Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 28 UK Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 29 Germany Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 30 Germany Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 31 Germany Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 32 Germany Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 33 Spain Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 34 Spain Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 35 Spain Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 36 Spain Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 37 Italy Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 38 Italy Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 39 Italy Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 40 Italy Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 41 France Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 42 France Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 43 France Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 44 France Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 45 Rest of Europe Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 46 Rest of Europe Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 47 Rest of Europe Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 48 Rest of Europe Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 49 Asia Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 50 Asia Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 51 Asia Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 52 Asia Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 53 China Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 54 China Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 55 China Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 56 China Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 57 Japan Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 58 Japan Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 59 Japan Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 60 Japan Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 61 India Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 62 India Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 63 India Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 64 India Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 65 Australia Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 66 Australia Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 67 Australia Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 68 Australia Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 69 South Korea Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 70 South Korea Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 71 South Korea Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 72 South Korea Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 73 Latin America Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 74 Latin America Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 75 Latin America Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 76 Latin America Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 77 Brazil Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 78 Brazil Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 79 Brazil Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 80 Brazil Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 81 Mexico Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 82 Mexico Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 83 Mexico Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 84 Mexico Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 85 Rest of Latin America Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 86 Rest of Latin America Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 87 Rest of Latin America Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 88 Rest of Latin America Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 89 Middle East and Africa Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 90 Middle East and Africa Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 91 Middle East and Africa Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 92 Middle East and Africa Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 93 GCC Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 94 GCC Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 95 GCC Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 96 GCC Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 97 Africa Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 98 Africa Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 99 Africa Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 100 Africa Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Point of Care Molecular Diagnostics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Point of Care Molecular Diagnostics Market: Quality Assurance
  • FIG. 5 Global Point of Care Molecular Diagnostics Market, By Product & Service, 2022
  • FIG. 6 Global Point of Care Molecular Diagnostics Market, By Technology, 2022
  • FIG. 7 Global Point of Care Molecular Diagnostics Market, By Application, 2022
  • FIG. 8 Global Point of Care Molecular Diagnostics Market, By End User, 2022
  • FIG. 9 Global Point of Care Molecular Diagnostics Market, By Geography, 2022
  • FIG. 10 Market Geographical Opportunity Matrix - Global Point of Care Molecular Diagnostics Market, 2022
  • FIG. 11 Market Positioning of Key Point of Care Molecular Diagnostics Market Players, 2022
  • FIG. 12 Global Point of Care Molecular Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 13 Global Point of Care Molecular Diagnostics Market, By Product & Service, 2022 Vs 2031, %
  • FIG. 14 Global Point of Care Molecular Diagnostics Market, By Technology, 2022 Vs 2031, %
  • FIG. 15 Global Point of Care Molecular Diagnostics Market, By Application, 2022 Vs 2031, %
  • FIG. 16 Global Point of Care Molecular Diagnostics Market, By End User, 2022 Vs 2031, %
  • FIG. 17 U.S. Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 18 Canada Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 19 Rest of North America Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 20 UK Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 21 Germany Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 22 Spain Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 23 Italy Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 24 France Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 25 Rest of Europe Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 26 China Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 27 Japan Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 28 India Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 29 Australia Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 30 South Korea Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 31 Rest of Asia Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 32 Brazil Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 33 Mexico Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 34 Rest of Latin America Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 35 GCC Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 36 Africa Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 37 Rest of Middle East and Africa Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031